BTT Medical Institute Unveils Groundbreaking ALS Treatment
BTT Medical Institute, alongside btt Corp., has made a historic announcement: a documented case showing the complete reversal of amyotrophic lateral sclerosis (ALS), a disease considered terminal until now. This significant advancement, revealed through the innovative Computerized Brain-Guided Intelligent Thermofebrile Therapy (CBIT2), has provided hope to many facing this daunting diagnosis.
The first patient to undergo this therapy is a 56-year-old woman from Illinois, previously diagnosed with progressive ALS. Despite receiving conventional treatments, her condition continued to worsen. However, after initiating treatment with CBIT2, she has experienced a phenomenal recovery. Tests showed no signs of motor neuron damage, confirming that she no longer meets the criteria for ALS.
Dr. M. Marc Abreu, the founder of BTT and Chief Medical Officer, highlighted that this milestone represents a transformative shift in ALS treatment, emphasizing physical principles over traditional chemical therapies. Utilizing a Nobel Prize-winning principle that once turned the tide against dementia paralytica, the team has modernized this approach with cutting-edge technology and artificial intelligence.
The Mechanism Behind the Breakthrough
CBIT2 works by inducing a therapeutic form of fever through a meticulously controlled feedback process, stimulating the body's natural defenses. This innovative therapy has been shown to activate heat shock proteins (HSPs) in the brain, which are essential for the recovery of neuronal function and the removal of toxic proteins associated with ALS.
Patient Experience and Results
The patient, Moira Papp, shared her journey, recounting how she transitioned from being unable to walk or speak to regaining her independence. She expressed immense gratitude for the treatment that revitalized her life when all hope appeared lost. Her success story is a testament to the profound impact of this therapy.
Transformative Treatment Outcomes
The treatment led to remarkable results, such as:
- Complete electrophysiological improvement, signaling a return to normal function of the motor neurons.
- Normalization of key biomarkers, which are crucial for assessing recovery.
- Significant induction of brain protective molecules, enhancing overall health.
- Restoration of essential motor functions, including improved swallowing and speech.
- Cognitive improvements and regaining the ability to participate in complex activities like golf and swimming.
Broader Implications of BTT's Technology
The implications of this treatment extend far beyond ALS. The shared pathological features of various neurological disorders suggest that BTT's pioneering approach could offer solutions for conditions such as:
- Alzheimer's disease
- Parkinson's disease
- Huntington's disease
- Multiple system atrophy
- Autism Spectrum Disorder
This technological advancement presents an exciting future for neurology, potentially reshaping treatment for numerous neurological disorders. During key discussions at the G7 Summit, the urgency of addressing global brain health was underscored, as millions are affected by these conditions worldwide.
The Vision of BTT Medical Institute
Dr. Abreu emphasized the potential of their technology in tackling one of the most challenging public health crises. With governmental support from the U.S., this pioneering therapy is positioned to offer hope to countless individuals. BTT Medical Institute aims to continue leading in innovation and patient care, leveraging advanced technology to transform the lives of those with neurological conditions.
Conclusion
The revolutionary progress made by BTT Medical Institute and btt Corp. with CBIT2 signifies a monumental leap in the treatment of ALS and beyond, highlighting the power of science and technology in improving health outcomes. With ongoing efforts and further clinical trials set to begin, the future looks bright for patients and the medical community alike.
Frequently Asked Questions
What is CBIT2 therapy?
CBIT2 is a noninvasive treatment approach that utilizes brain-guided technology to induce therapeutic fever, activating natural recovery processes in the brain.
How does the therapy work?
The therapy encourages the production of heat shock proteins which help restore neuronal function and remove misfolded proteins in patients with ALS.
What are the success stories from this treatment?
One notable case involved a woman who completely reversed her ALS symptoms and regained her ability to walk, talk, and engage in recreational activities.
What are the future plans for this technology?
BTT Medical Institute plans to initiate clinical trials to further validate the efficacy of CBIT2 for ALS and explore its use in treating other neurological disorders.
How does BTT address the global brain health crisis?
BTT's innovative therapies aim to provide effective solutions for the rising prevalence of neurological diseases, tackling one of the leading causes of disability worldwide.
